The intensification of the aging process has led to a substantial demand for health management of chronic disease. In recent years, retail pharmacies, with their convenience and cost-effectiveness, have increasingly demonstrated their role in chronic disease management, gradually becoming important service stations and platforms of chronic disease prevention and control. Particularly, the outpatient mutual aid guarantee reform under employees’ medical insurance has incorporated designated retail pharmacies into reimbursement of outpatient pooling, providing strategic opportunities for the in-depth development of pharmacies. This paper analyzes the mechanisms of retail pharmacies' participation in chronic disease management, focusing on the characteristics and needs of the chronic disease patient group. Practice in developed countries presents four innovative mechanisms: multi-stakeholder collaboration, classified and graded management, specialized pharmacist training, and digital service, which offer valuable experience and lessons for China. To further promote the transformation and upgrading of chronic disease management services in retail pharmacies, it is essential to optimize development pathways by clarifying positioning, cultivating talents, improving prescription circulation, innovating service methods, and strengthening medical insurance regulation.
Key words
retail pharmacies /
chronic disease management /
outpatient fund pooling
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 国家卫生健康委员会.健康中国行动推进委员会办公室2019年7月29日新闻发布会[EB/OL].(2019-07-29)[2024-09-03].http://www.nhc.gov.cn/xcs/s7847/201907/520f21e5ac234785bcc363a286866fb0.shtml.
[2] 世界银行. 创建健康和谐生活:遏制中国慢性病流行[R].2011.
[3] RB ROTHENBERG, JP KOPLAN.Chronic disease in the 1990s[J].Annual review of public health,1990,11(1):267.
[4] 申曙光,马颖颖.我国老年医疗保障的制度创新:保险抑或福利?[J].社会科学战线,2014(3):180-187.
[5] 中国报告网.2019年我国零售药店行业销售额、市场规模、数量及店均服务人数[EB/OL].(2020-09-22)[2024-09-03].http://data.chinabaogao.com/yiyao/2020/09225161162020.html.
[6] 姜明欢,王乐,王文娟,等.陕西省公立医院和零售药店基本药物价格及可获得性比较研究[J].中国药房,2013,24(4):308-313.
[7] 魏威,张尚武,熊巨洋.我国构建家庭医疗签约服务制度的机制探讨[J].中国全科医学,2016,19(10):1129-1132.
[8] 罗琴,梁海伦.基于慢性病护理模式的家庭医生制度推进现实问题分析[J].中国全科医学,2020,23(14):1833-1838.
[9] HERBERTCHESHIRE L.Contemporary strategies for rural community development in Australia: a governmentality perspective[J]. Journal of rural studies. 2000, 16(2): 203-215.
[10] 范璟蓉,李歆.美国合作药物治疗管理及对我国的启示[J].中国新药杂志,2011,20(23):2381-2386.
[11] 代宝珍,周绿林,余悦.基于农村医疗保障制度的老年居民慢性病管理理论框架构建[J].西北人口,2013,34(04):83-89.
[12] 应亮,杨辉.澳大利亚疾病管理计划及其对中国的启示[J].中国全科医学,2019,22(34):4184-4189.
[13] HEPLER C D, STRAND L M.Opportunities and responsibilities in pharmaceutical care[J]. American journal of hospital pharmacy,1990,47(3):533-543.
[14] 陈云,邹宜諠,邵蓉,等.美国、英国、澳大利亚社区药师职责扩展的实践及对我国的启示[J].中国药房,2017,28(34):4758-4762.
[15] General Pharmaceutical Council. Pharmacist independent prescriber[EB/OL].[2024-09-03]. http://www.pharmacy-regulation.org/education/pharmacist-independent-prescriber.
[16] 山本武道. 向健康护理型药店转型[J].中国药店,2015(1):52-55.
[17] 于翠婷. 中日比较视域下我国零售药店药学服务能力研究[D].南京:南京中医药大学,2019.
[18] 钟沈军,王艳,红刘向.国外通行的医药分业[J].瞭望,2007(20):25-27.
[19] 高弘杨.沃尔格林:线下药店才是布局的核心[J].中国药店,2019(09):68-69.
[20] 郑金华,罗秀针,何玉婷.人口老龄化背景下闽南地区零售药店经营策略研究[J].中医药管理杂志,2020,28(11):114-118.
[21] 国家药品监督管理局执业药师资格认证中心,2024年9月全国执业药师注册情况[EB/OL].(2024-10-10)[2024-11-03].http://www.cqlp.org/info/link.aspx?id=7255&page=1.
[22] 曹阳,闫岩.我国执业药师发展现状及对策[J].中国执业药师,2015,12(1):43-47.
[23] 王震,王曼玉.门诊共济保障方式改革、零售药店发展与处方流转[J].中国医疗保险,2024(03):34-42.
